Poly-ICLC (Hiltonol) is a TLR3 agonist comprised of synthetic dsRNA, which stimulates the production of pro-inflammatory cytokines and IFN-γ [97,98,99,100]; however, there are mixed results regarding TLR3’s role in tumor cell intrinsic phenotypes [101,102]. This evidence concerns the gene TLR3 and neoplasm.